SurroMed is developing novel technologies useful for phenotypic analysis of samples and biomarker discovery and validation.

Currently SurroMed is developing the next generation cytometry instrumentation, - the SurroSpot™ cytometry system - supported by a grant by the Advanced Technologies Program of the National Institutes of Standards and Technologies.

Press Releases

In spring of 2002 SurroMed spun off Nanoplex Technologies, a company developing the Nanobarcodes™ particles technology and other nanoparticle-based products for life science research and other applications.